Sebastien André
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sebastien André has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Blanche Aguida
Institut de Biologie Paris-Seine, Sorbonne Université/CNRS, F-75005 Paris, France
1 shared publication - Dominique Archambault
Université Paris 8-Vincennes-Saint-Denis, THIM (E.A. 4004 CHArt)
1 shared publication - Jimmy David Bell
Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom
1 shared publication - Margaret Ahmad
UMR CNRS 8256 (B2A), Université Paris VI, 75005 Paris, France
1 shared publication - Marie-Marthe Chabi
UMR8256, CNRS, IBPS, Sorbonne University, 75005 Paris, France
1 shared publication - Marootpong Pooam
Department of Biology, Faculty of Science, Naresuan University, Phitsanulok 65000, Thailand
1 shared publication
Latest Publications
- Open Access
- 2 October 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (10) , 1824
Near-Infrared Light Exposure Triggers ROS to Downregulate Inflammatory Cytokines Induced by SARS-CoV-2 Spike Protein in Human Cell Culture
The leading cause of mortality from SARS-CoV-2 is an exaggerated host immune response, triggering cytokine storms, multiple organ failure and death. Current drug- and vaccine-based therapies are of limited efficacy against novel viral variants. Infrared therapy is a non-invasive and safe method that has proven effective against inflammatory conditions for over 100 years. However, its mechanism of action is poorly understood and has not received widespread acceptance. We herein investigate whether near-infrared (NIR) light exposure in human primary alveolar and macrophage cells could downregulate inflammatory cytokines triggered by the SARS-CoV-2 spike (S) protein or lipopolysaccharide (LPS), and via what underlying mechanism. Our results showed a dramatic reduction in pro-inflammatory cytokines within days of NIR light treatment, while anti-inflammatory cytokines were upregulated. Mechanistically, NIR light stimulated mitochondrial metabolism, induced transient bursts in reactive oxygen species (ROS) and activated antioxidant gene transcription. These, in turn, downregulated ROS and inflammatory cytokines. A causal relationship was shown between the induction of cellular ROS by NIR light exposure and the downregulation of inflammatory cytokines triggered by SARS-CoV-2 S. If confirmed by clinical trials, this method would provide an immediate defense against novel SARS-CoV-2 variants and other inflammatory infectious diseases.
- 2 October 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (10) , 1824
Open AccessNear-Infrared Light Exposure Triggers ROS to Downregulate Inflammatory Cytokines Induced by SARS-CoV-2 Spike Protein in Human Cell Culture
The leading cause of mortality from SARS-CoV-2 is an exaggerated host immune response, triggering cytokine storms, multiple organ failure and death. Current drug- and vaccine-based therapies are of limited efficacy against novel viral variants. Infrared therapy is a non-invasive and safe method that has proven effective against inflammatory conditions for over 100 years. However, its mechanism of action is poorly understood and has not received widespread acceptance. We herein investigate whether near-infrared (NIR) light exposure in human primary alveolar and macrophage cells could downregulate inflammatory cytokines triggered by the SARS-CoV-2 spike (S) protein or lipopolysaccharide (LPS), and via what underlying mechanism. Our results showed a dramatic reduction in pro-inflammatory cytokines within days of NIR light treatment, while anti-inflammatory cytokines were upregulated. Mechanistically, NIR light stimulated mitochondrial metabolism, induced transient bursts in reactive oxygen species (ROS) and activated antioxidant gene transcription. These, in turn, downregulated ROS and inflammatory cytokines. A causal relationship was shown between the induction of cellular ROS by NIR light exposure and the downregulation of inflammatory cytokines triggered by SARS-CoV-2 S. If confirmed by clinical trials, this method would provide an immediate defense against novel SARS-CoV-2 variants and other inflammatory infectious diseases.